Cannara Biotech Inc. (TSX:LOVE)

Cannara Biotech Balance Sheet

Financials in millions CAD. Fiscal year is September - August.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2026	Aug 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021
Cash & Equivalents	21.81	14.36	6.62	4.27	12.11	8.16
Cash & Short-Term Investments	21.81	14.36	6.62	4.27	12.11	8.16
Cash Growth	51.37%	116.91%	55.02%	-64.75%	48.48%	4.99%
Accounts Receivable	18.52	14.11	13.04	10.59	8.62	2.92
Other Receivables	-	-	-	-	-	0.05
Receivables	18.52	14.11	13.04	10.59	8.62	2.97
Inventory	55.63	51.33	40.07	33.77	18.98	7.41
Prepaid Expenses	1.73	2.36	2.85	3.06	1.28	0.71
Other Current Assets	-	-	4.9	-	-	-
Total Current Assets	97.69	82.16	67.47	51.7	40.99	19.25
Property, Plant & Equipment	92.96	86	84.94	89.44	83.4	71.75
Other Intangible Assets	2.68	-	-	-	-	-
Long-Term Accounts Receivable	-	-	-	-	-	0.07
Long-Term Deferred Tax Assets	-	-	1.95	-	-	-
Long-Term Deferred Charges	-	0.05	-	0.06	-	-
Other Long-Term Assets	1.15	0.44	0.36	0.33	1.22	0.95
Total Assets	194.49	168.65	154.72	141.52	125.62	92.02

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2026	Aug 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021
Accounts Payable	10.63	11	9.42	8.12	8.85	6.19
Accrued Expenses	11.94	9.77	7.94	6.86	0.77	0.07
Short-Term Debt	6.76	6.76	6.26	3	-	-
Current Portion of Long-Term Debt	2.86	6.26	2.97	2.97	1.97	0.3
Current Portion of Leases	0.16	0.28	0.28	0.08	0.22	0.23
Current Unearned Revenue	0.23	0.13	0.13	0.16	0.05	0.04
Total Current Liabilities	32.57	34.2	27	21.18	11.86	6.83
Long-Term Debt	27.2	28.17	38.45	39.64	46.19	20.15
Long-Term Leases	0.02	0.11	0.37	0.1	0.02	0.22
Long-Term Unearned Revenue	1.59	0.88	0.94	0.86	0.82	0.71
Long-Term Deferred Tax Liabilities	7.25	3.07	-	-	-	-
Total Liabilities	68.64	66.43	66.77	61.78	58.88	27.91

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2026	Aug 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021
Common Stock	104.1	89.76	88.52	88.8	83.3	83.21
Additional Paid-In Capital	14.02	12.28	12.33	10.35	9.72	9.41
Retained Earnings	7.72	0.18	-12.9	-19.34	-26.3	-28.61
Comprehensive Income & Other	-	-	-	-0.07	0.02	0.1
Total Common Equity	125.85	102.22	87.95	79.74	66.74	64.12
Shareholders' Equity	125.85	102.22	87.95	79.74	66.74	64.12
Total Liabilities & Equity	194.49	168.65	154.72	141.52	125.62	92.02

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2026	Aug 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021
Total Debt	37	41.58	48.33	45.78	48.39	20.9
Net Cash (Debt)	-15.19	-27.22	-41.71	-41.51	-36.28	-12.74
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.16	-0.29	-0.46	-0.46	-0.41	-0.17
Filing Date Shares Outstanding	98.78	94.9	90.02	90.02	87.7	87.65
Total Common Shares Outstanding	98.78	91.43	90.02	90.31	87.7	87.65
Working Capital	65.12	47.96	40.47	30.51	29.13	12.41
Book Value Per Share	1.27	1.12	0.98	0.88	0.76	0.73
Tangible Book Value	123.16	102.22	87.95	79.74	66.74	64.12
Tangible Book Value Per Share	1.25	1.12	0.98	0.88	0.76	0.73
Land	2.33	2.33	2.33	2.45	2.45	2.45
Buildings	79.37	77.76	76.71	75.48	64.3	44.79
Machinery	30.82	25.49	20.65	18.57	14.22	8.47
Construction In Progress	9.29	4.65	4.71	6.73	11.53	21.23

Data Source: S&P Global Market Intelligence Last updated: May 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 16, 2026

Data Sources Report a data error